Home Forums |
|
MDS Myelodysplastic syndromes |
|
Thread Tools | Search this Thread |
#1
|
|||
|
|||
Update on Diagnosis and Prognostic Evaluation of MDS
Update on developments in the diagnosis and prognostic evaluation of patients with myelodysplastic syndromes (MDS): Consensus statements and report from an expert workshop...
An interesting report on the state of art for MDS diagnosis from Luekemia Research. It's free on CME today when you log in or register as required. http://www.lrjournal.com/article/S01...537-6/fulltext
__________________
Ric: Low-risk MDS (blasts <4%); 4 cycles Revlimid no positive response; PRBC transfusion dependent; so far, 392'units' over 8 3/4 years; BMB #4 (15/04/01) shows evolution to AML (blasts 20-30%) 47,XY,del(5) (q22q35),+21[24][cp24]/46,XY(1). |
#2
|
|||
|
|||
Login Unsuccessful
I registered at the site, but am unable to download the article. It is a free site?
__________________
Sherry Baby 62 Diagnosed 2/11/12 MDS to AML-6; del 20q and trisomy 21; Vidaza 3 month trial unsuccessful; ALLO BMT 7/2/12; Sister Donor 10/10 match; Chronic GVHD mucous membranes, otherwise all's well :0) |
#3
|
|||
|
|||
Article was free last month, but free access has expired now for this link. Sorry.
__________________
Ric: Low-risk MDS (blasts <4%); 4 cycles Revlimid no positive response; PRBC transfusion dependent; so far, 392'units' over 8 3/4 years; BMB #4 (15/04/01) shows evolution to AML (blasts 20-30%) 47,XY,del(5) (q22q35),+21[24][cp24]/46,XY(1). |
Thread Tools | Search this Thread |
|
|
Similar Threads | ||||
Thread | Thread Starter | Forum | Replies | Last Post |
New Tool: MDS Classification | Marrowforums | Site Announcements | 7 | Tue Jan 4, 2011 05:12 AM |
The lower risk MDS patient at risk of rapid progression | akita | MDS | 0 | Mon Dec 27, 2010 04:28 AM |